Discusses what is unique about the company and what newsflow investors can expect - Michel Baijot, CEO of Asit Biotech 00:00:00

Share On Facebook Share On Twitter

In this interview Michel Baijot, CEO of Asit Biotech, discusses what is unique about the company and what newsflow investors can expect from ASIT in the second half of 2019.

Recent Videos